On April 30, 2025, Kent Lake PR LLC, a holder of approximately 7.7% of Quanterix Corporation's common stock, issued a statement criticizing the company’s amended merger agreement with Akoya Biosciences. Kent Lake viewed the removal of the shareholder voting requirement as a 'blatant disregard for the will of shareholders.'
Kent Lake's statement followed Quanterix's announcement of revised merger terms, which included a reduction in the number of shares to be issued and a cash component, but also eliminated the need for a Quanterix shareholder vote. This move was seen by Kent Lake as an attempt to bypass shareholder opposition.
The activist investor reiterated its belief that the merger is not in the best interests of Quanterix shareholders and highlighted ongoing concerns about corporate governance and the strategic rationale behind the transaction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.